This is a working overview of research chemical, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | -20 °C or lower | Desiccated and protected from light |
| Common analytical method | LC-MS/MS | Detects parent drug and metabolites |
| Solubility class | Lipophilic; soluble in organic solvents | Low aqueous solubility |
| Molecular weight | 437.94 g/mol | Calculated from reported formula |
| Synonyms | SR9009; REV-ERB agonist | Code name used in scientific literature |
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Estimated Average Requirements (EARs) and Recommended Dietary Allowances (RDAs) for vitamins and minerals, PRIs for the European Union (same concept as RDAs), followed by what three government organizations deem to be the safe upper intake. RDAs are set higher than EARs to cover people with higher-than-average needs. Adequate Intakes (AIs) are set when there is insufficient information to establish EARs and RDAs. Countries establish tolerable upper intake levels, also referred to as upper limits (ULs), based on amounts that cause adverse effects. Governments are slow to revise information of this nature. For the U.S. values, except calcium and vitamin D, all data date from 1997 to 2004.
=== Mania === Psychedelics can induce hypomania or mania in people with bipolar disorder. This is of low but clinically meaningful incidence (5.8% in clinical trials, 30% in naturalistic settings) and is typically acute and self-limited.
Middleton is dyslexic. He read from the New Revised Standard Version of the Bible at the 2011 wedding of his sister Catherine to Prince William. In 2019, he disclosed his struggles with depression and attention deficit hyperactivity disorder, which he attributed to public scrutiny from age 23 as a result of his eldest sister's relationship. He sought treatment in 2017, undertaking cognitive behavioral therapy. Middleton also spent "restorative time" at the Glen Affric Estate, where he has hosted deer-stalking parties. The estate is owned by his sister Philippa's father-in-law. In the same year, he penned a column in the Daily Mail about mental health. Middleton is an ambassador for the Pets As Therapy charity and has credited his dog, Ella, for helping him through his depression. He breeds dogs, owning six, as well as one rescue lamb. Middleton also keeps bees on the grounds of Bucklebury Manor. In April 2020, he founded the Paw Print Fund in aid of animal welfare charities. Middleton was in a relationship with actress Donna Air from 2013 to 2018. Middleton met French financial analyst Alizée Thevenet (b. 30 November 1989) in 2018. She is the daughter of retired diplomat Jean-Gabriel Thevenet. Middleton and Alizée announced their engagement in September 2019. On 11th September 2021, Alizée's mother, along with James's family, attended the wedding in the village of Bormes-les-Mimosas in the south of France where Alizée's family lives. Alizée's father had died some months before the wedding.
==== Insulin resistance ==== Obesity has been contributing to increased insulin resistance in the global population. Insulin resistance increases hyperglycemia because the body becomes oversaturated by glucose. Insulin resistance desensitizes insulin receptors, preventing insulin from lowering blood sugar levels. The leading cause of hyperglycemia in type 2 diabetes is the failure of insulin to suppress glucose production by glycogenolysis and gluconeogenesis due to insulin resistance. Insulin normally inhibits glycogenolysis, but fails to do so in a condition of insulin resistance, resulting in increased glucose production. In the liver, FOXO6 normally promotes gluconeogenesis in the fasted state, but insulin blocks FOXO6 upon feeding. In a condition of insulin resistance, insulin fails to block FOXO6, resulting in continued gluconeogenesis even upon feeding.
Ben Howlett (born 21 October 1988) is a former professional Australian rules footballer who played for the Essendon Football Club in the Australian Football League (AFL). Howlett was selected by Essendon with pick 30 in the 2010 rookie draft, as a 21-year-old from Peel Thunder in the West Australian Football League. His final season with Peel Thunder saw him claim the club's best and fairest award. He was promoted to Essendon's senior list in the 2010 season. Howlett, along with 33 other Essendon players, was found guilty of using a banned performance-enhancing substance, thymosin beta-4, as part of Essendon's sports supplements program during the 2012 season. He and his teammates were initially found not guilty in March 2015 by the AFL Anti-Doping Tribunal, but a guilty verdict was returned in January 2016 after an appeal by the World Anti-Doping Agency. He was suspended for one season which, with backdating, ended in November 2016; as a result, he served approximately fourteen months of his suspension and missed the entire 2016 AFL season. Howlett was delisted at the conclusion of the 2017 AFL season. He returned home to WA and signed with the club he was originally drafted from, Peel Thunder in the WAFL, for the 2018 season. In 2019, Howlett was named captain of the club, taking over from dual premiership captain Gerald Ugle. In Round 9 of the 2021 WAFL season Howlett played his 100th game for Peel Thunder against Swan Districts before announcing his retirement from WAFL footy at the end of that season.
Sources: en.wikipedia.org
=== CPM, thiol-specific dyes === Alexandrov et al. (2008) published a variation on the Thermofluor assay where SYPRO Orange was replaced by N-[4-(7-diethylamino-4-methyl-3-coumarinyl)phenyl]maleimide (CPM), a compound that only fluoresces after reacting with a nucleophile. CPM has a high preference for thiols over other typical biological nucleophiles and therefore will react with cysteine side chains before others. Cysteines are typically buried in the interior of a folded protein as they are hydrophobic. When a protein denatures cysteine thiols become available and a fluorescent signal can be read from reacted CPM. The excitation and emission wavelengths for reacted CPM are 387 nm/ 463 nm so a fluorescence plate reader or a qPCR machine with specialized filters is required. Alexandrov et al. used the technique successfully on the membrane proteins Apelin GPCR and FAAH as well as β-lactoglobin which fibrillates on heating rather than going to a molten globule.
=== Glycomics === Glycomics is the study of the carbohydrate components of cells. Though not exclusive to glycoproteins, it can reveal more information about different glycoproteins and their structure. One of the purposes of this field of study is to determine which proteins are glycosylated and where in the amino acid sequence the glycosylation occurs. Historically, mass spectrometry has been used to identify the structure of glycoproteins and characterize the carbohydrate chains attached.
In December 2020, Collins assisted with the launch of the free-to-play lottery app Bravospeed, for which she appeared in an online advertisement in academic dress explaining the app's rules. In July 2021, Collins teamed up with Durex alongside Ollie Locke and Alix Fox to create the Roadmap to Sexual Satisfaction, a guide in which she provided her tips and advice for getting physical, saying that "Confidence [was] the key to positive, satisfying, intimacy" and that "sexiness comes from within". In May 2022, Collins announced she was working with the brand again to support the launch of their new range of sex toys. She promoted three different vibrators and expressed the importance of "self-love" adding that the use of sex toys was "empowering" and that she wanted to help break the taboo around talking about them. In August 2021, Collins was announced as the new face of the laundry detergent brand Surf and released her own limited edition detergent and capsules as part of the company's "Diva Divine" range, exclusive to Asda supermarkets. In October 2021, Collins became a speaker at Big Business Events, a business development service in which she offered her tips for business growth and shared her own experiences during a 3-day live event. In November 2021, Collins announced her collaboration with Amazon Handmade, in which she worked with interior designers Paul Moneypenny and Siobhan Murphy to create a bespoke 33-piece collection featuring homeware, skincare and other gift items, titled the Gemma Collins & Friends Christmas Collection.
=== Mechanism of mineralization === Mineralization occurs in two phases: the vesicular phase and the fibrillar phase. Vesicular phase: Matrix vesicles, measuring 30-200 nm in diameter, are released from the apical membrane of osteoblasts into the newly formed bone matrix. These vesicles contain alkaline phosphatase, adenosine triphosphatase (ATPase), and inorganic pyrophosphatase, and act as seeding sites for hydroxyapatite crystal formation through localized enzymatic accumulation of calcium and phosphate. Role of alkaline phosphatase: Osteoblasts secrete alkaline phosphatase, which participates in bone mineralization by hydrolyzing pyrophosphate, an inhibitor of mineralization, thereby increasing local inorganic phosphate availability for hydroxyapatite formation. Crystal propagation: Crystal growth proceeds from initial foci in matrix vesicles to form spheroids, which gradually coalesce to form a network of apatite crystals. As the matrix matures, hydroxyapatite microcrystals are organized into a sophisticated composite within the collagen layer by nucleation in the protein lattice.
{\displaystyle {\begin{cases}{\ce {^{244}_{96}Cm ->[{\ce {(\alpha,n)}}] ^{247}_{98}Cf ->[\epsilon][3.11 \ {\ce {h}}] ^{247}_{97}Bk}}\\{\ce {^{244}_{96}Cm ->[{\ce {(\alpha,p)}}] ^{247}_{97}Bk}}\end{cases}}}
Sources: en.wikipedia.org
Liquid chromatography-tandem mass spectrometry is a common approach. It can detect the parent compound and its metabolites in biological matrices.
Research samples are typically kept frozen, desiccated, and protected from light. Stock solutions are often aliquoted to reduce freeze-thaw cycles.
High-performance liquid chromatography and nuclear magnetic resonance are standard for purity and identity. Mass spectrometry confirms molecular weight.
SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.